SEC Form 3 · accession 0000899243-18-008631
Q32 Bio Inc. · QTTB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Arthur Tzianabos
Officer — President & CEO · Director
Period of report
Mar 27, 2018
Accepted (ET)
Mar 27, 2018 · 5:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661998
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 190,005 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionsF1 | $0.47 | holding | — | — | — | — | Apr 22, 2026 | Common Stock | 462,135 | — | D |
| Employee Stock OptionF2 | $6.63 | holding | — | — | — | — | Dec 7, 2027 | Common Stock | 514,653 | — | D |
Explanation of responses
- F1The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in equal monthly installments over a three year period thereafter. The vesting commencement date for this option was April 1, 2016.
- F2The option vests and becomes exercisable upon the Reporting Person's completion of each full month of service after January 1, 2018.
Remarks
Exhibit 24 - Power of Attorney.